Skip to main content
Figure 4 | BMC Dermatology

Figure 4

From: What determines patient preferences for treating low risk basal cell carcinoma when comparing surgery vs imiquimod? A discrete choice experiment survey from the SINS trial

Figure 4

Modelling patient preferences: the proportion of respondents (%) with positive effect of particular characteristic. Note: The output from the logistic regression model used to inform these estimates is presented in Tables 3 (whole sample) and 4 (subgroups with experience and with no experience of BCC symptoms and treatment, and their comparison). For ‘MODERATE SIDE EFFECTS’ and ‘NORMAL APPEARANCE’ differences in preference distribution between subgroups (with experience vs. with no experience of BCC symptoms and treatment) are significant at the 95% level.

Back to article page

BMC Dermatology

ISSN: 1471-5945

Contact us